[{"Assets_0_Q1_USD":7817365000.0,"NetIncomeLossConverted_1_Q1_USD":248931000.0,"StockholdersEquity_0_Q1_USD":4866021000.0,"EarningsPerShareBasic_1_Q1_USD":2.36,"EarningsPerShareDiluted_1_Q1_USD":2.16,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":355901000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":115106000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":105572000.0,"RevenuesConverted_1_Q1_USD":858245000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS INC","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20170504"}]